RoboCT

company

About

RoboCT is a developer of exoskeleton robot technology that helps patients with lower-body motor dysfunction learn to walk.

Details

Last Funding Type
Seed
Last Funding Money Raised
¥1M
Industries
Robotics,Software
Founded date
Jan 5, 2017
Number Of Employee
11 - 50
Operating Status
Active
Also Known As
程天科技, Cheng Tian Keji, 杭州程天科技发展有限公司

RoboCT is a developer of exoskeleton robot technology that helps patients with lower-body motor dysfunction learn to walk. The company is currently focusing on the field of rehabilitation and elderly care, they provide intelligent products and solutions for medical care institutions and individual users by combining human-computer interaction technology, artificial intelligence technology, data analysis, and cloud computing. To improve human body function through robot technology, and to expand the use of exoskeleton technology in health, industry, transportation, security, entertainment, and other fields.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
¥121M
RoboCT has raised a total of ¥121M in funding over 2 rounds. Their latest funding was raised on Feb 10, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 10, 2022 Series A ¥100M 4 Fortune Venture Capital Detail
Mar 29, 2021 Series A 1 BlueRun Ventures Detail
May 14, 2018 Series A ¥20M 1 Naton Detail
Nov 9, 2016 Seed ¥1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
6
RoboCT is funded by 6 investors. Fortune Venture Capital and Naton are the most recent investors.
Investor Name Lead Investor Funding Round
Fortune Venture Capital Yes Series A
Naton Yes Series A
BlueRun Ventures Series A
Essence Securities Series A
Poly Capital Series A
Chisong Touzi Seed

Employee Profiles

Number of Employee Profiles
4
RoboCT has 4 current employee profiles, including Executive Tian Wang
Executive
Executive
Executive
Board member